|
Acasti Pharma Inc (NASDAQ: ACST) |
|
Acasti Pharma Inc
ACST's Fundamental analysis
Select the Comparisons :
|
|
Select the Ratio:
|
|
|
Acasti Pharma Inc 's sales fell
in I. Quarter 2024 from the same quarter a year ago.
Major Pharmaceutical Preparations industry recorded
growth of revenues by 5.18 %
Acasti Pharma Inc net loss decreased from $-4 millions, to $-3 millions in I. Quarter 2024,
• More on ACST's Growth
|
|
Acasti Pharma Inc realized a net loss in trailing twelve months.
Acasti Pharma Inc realized cash reduction of $ -0.2 per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.
• More on ACST's Valuation
|
|
|
|
|
Acasti Pharma Inc realized net loss in trailing twelve months.
Acasti Pharma Inc realized cash outflow of $ -0.2per share in trailing twelve-month period. |
Company |
- |
PE TTM
|
Industry |
- |
PE TTM
|
|
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.1.
Acasti Pharma Inc Price to Book Ratio is at 0.62 lower than Industry Avg. of 77.28. and higher than S&P 500 Avg. of 0.01
• More on ACST's Valuation
|
|
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights
reserved.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com